← Evidence map

ArticleGastro hep advances2026

Prospective Evaluation of Ustekinumab Dose Intensification in Inflammatory Bowel Diseases.

Rahul S Dalal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42602797